Health and Growth

FIELDS:
  • Environment, Consumers and Health
  • Research, Innovation and Technology
BUDGET: 449,39 € millions for the 2013 (398.4€ 2011 price)
GENERAL OBJECTIVE:
  • To develop common tools and mechanisms at EU level to address shortages of resources, both human and financial and to facilitate up-take of innovation in healthcare in order to contribute to innovative and sustainable health systems;
  • To increase access to medical expertise and information for specific conditions also beyond national borders and to develop shared solutions and guidelines to improve healthcare quality and patient safety in order to increase access to better and safer healthcare for EU citizens;
  • To identify, disseminate and promote the up-take of validated best practices for cost-effective prevention measures by addressing the key risk factors, namely smoking, abuse of alcohol and obesity, as well as HIV/AIDS, with a focus on the cross border dimension, in order to prevent diseases and promote good health;
  • To develop common approaches and demonstrate their value for better preparedness and coordination in health emergencies in order to protect citizens from cross-border health threats.
ELEGIBLE PARTNERS:

Legally established organisations, public authorities, public sector bodies, in particular research and health institutions, universities and higher education establishments and undertakings.

ELEGIBLE COUNTRIES:

The programme is open to the participation of: Member States; third countries, in particular of acceding countries, candidate countries and potential candidates benefiting from a pre-accession strategy; EFTA/EEA countries; neighboring countries and the countries to which the European Neighbourhood Policy (ENP) applies; and other countries in accordance with the conditions laid down by a relevant bilateral or multilateral agreement.

SUPPORTED ACTIONS:

1.Contributing to innovative and sustainable health systems:

  • Develop EU cooperation on Health Technology Assessment in the context of Directive 2011/24/EU on the application of patients rights in cross-borderhealthcare;
  • Promote the uptake of health innovation and e-Health by increasing the interoperability of e-Health applications; support the sustainability of EU health workforce by promoting effective forecasting and planning and efficient recruitment and retention strategies; provide expertise to assist Member States undertaking health systems reforms;
  • Support to the European Innovation Partnership on Active and Healthy Ageing, a pilot project under Europe2020 flagship initiative Innovation Union; actions required by or contributing to the objectives of EU legislation in the fields of medical devices as well ase-Health and Health Technology Assessment provisions in legislation on cross border healthcare; foster a health knowledge system, including Scientific Committees, to contribute to evidence-based decision making;
  • Increasing access to better and safer healthcare for citizens: set up accreditation and support European Reference Networks;
  • Support action on rare diseases including creation of European Reference Networks, information and registries based on the common criteria for accreditation;
  • Strengthen collaboration on patient safety and quality of healthcare, by increasing the availability of information to patients, exchange of best practices and development of guidelines;
  • Support action on chronic diseases care and research including development of European guidelines; develop guidelines to improve the prudent use of antimicrobials in human medicine and reduce the practices thatincrease antimicrobial resistance;
  • Actions required by or contributing to the objectives of EU legislation in the fields of tissues and cells, blood, organs, patients rights in cross-border healthcare and medicinal products;
  • Foster a health knowledge system, to contribute to evidence-based decision making

2.Promoting good health and preventing diseases:

  • Exchange best practices on key healthissues such as smoking prevention, abuse of alcohol and obesity;
  • Supporting the prevention of chronic diseases including cancer, by sharing knowledge and best practice and developing joint activities;
  • Actions required by or contributing to the objectives of EU legislation in the fields of tobacco products and advertisement;
  • Foster a health knowledge system, to contribute to evidence-based decision making.

3.Protecting citizens from cross border health threats:

  • Strengthen preparedness and response for serious cross border health threats;
  • Improve risk assessment capacity by providing additional capacities for scientific expertise and map existing assessments;
  • Support capacity building against health threats in Member States by inter alia developing preparedness and response planning and coordination, common approaches to vaccination, developing guidelines and mechanisms for joint procurement of medical countermeasures;
  • Actions required by or contributing to the objectives of EU legislation in the fields of communicable diseases and other health threats.
CO-FINANCING:

The level of Union co-financing for grants for actions, actions co-financed by the competent authorities of the Member States or third countries, or by non-governmental bodies mandated by these authorities and operating grants will be harmonised at 60% of eligible costs and up to 80% in cases of exceptional utility.

RESPONSIBLE BODY: DG Health and Consumers
Cron Job Starts